Patient Education and Duloxetine, Alone and in Combination, for Patients With Multisystem Functional Somatic Disorder

NCT06232473 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

424

Enrollment

OTHER

Sponsor class

Conditions

Functional Disorder

Interventions

BEHAVIORAL: Patient Education
DRUG: Duloxetine
DRUG: Benztropine Mesylate 0.5 MG and passive placebo RAP
BEHAVIORAL: Enhanced usual care

Sponsor

Aarhus University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]